BRCA2 mutation in Icelandic prostate cancer patients

Journal of Molecular Medicine

Volumn 75, Issue 10, 1997, Pages 758-761

  Sigurdsson, Stefan ^a,d   Thorlacius, Steinunn ^b   Tomasson, Jon ^a,c   Tryggvadottir, Laufey ^a,d   Benediktsdottir, Kristrun ^b   Eyfjörd, Jorunn E ^c   Jonsson, Eirikur ^d  

^a ICELANDIC CANCER SOCIETY   (Iceland)

^b ICELANDIC CANCER REGISTRY   (Iceland)

^c LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^d Reykjavik City Hospital   (Iceland)

Author keywords

BRCA2; Prognostic marker; Prostate cancer

Indexed keywords

TUMOR MARKER;

ARTICLE; BREAST; BREAST CANCER; CHROMOSOME 13; CLINICAL ARTICLE; FAMILY; GENE MUTATION; GENETIC ANALYSIS; GENETIC MARKER; HUMAN; HUMAN CELL; HUMAN TISSUE; ICELAND; MALE; PREVALENCE; PROSTATE CANCER; RELATIVE;

AGED; BRCA2 PROTEIN; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; EXONS; FEMALE; GENETIC MARKERS; HUMANS; ICELAND; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS; RISK FACTORS; SEQUENCE DELETION; SURVIVAL RATE; TRANSCRIPTION FACTORS;

EID: 0030870451     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090050162     Document Type: Article

References (17)

1. Potosky AL, Miller BA, Albertsen PC, Kramer BS (1995) The role of increasing detection in the rising incidence of prostate cancer. JAMA 273:548-552
2. Steinberg GD, Carter BS, Beaty TH, Childs B, Walsh PC (1990) Family history and the risk of postate cancer. Prostate 17:337-347
3. Johansson JE, Adami HO, Anderson SO, Bergström R, Holmberg L, Krusemo UB (1992) High 10 year survival rate in patients with early, untreated prostatic cancer. JAMA 267:2191-2196
4. Isaacs WB, Bova GS, Morton RA, Bussemakers MJG, Brooks JD, Ewing CM (1995) Molecular biology of prostate cancer progression. Cancer Surv 23:19-32
5. Gray 1C, Phillips SM, Lee SJ, Neoptolemos JP, Weissenbach J, Spurr NK (1995) Loss of the chromosomal region 10q23-25 in prostate cancer. Cancer Res 55:4800-4803
6. Smith JR, Freije D, Carpten JD, Gronberg H, Xu J, Isaacs SD, Brownstein MJ, Bova GS, Guo H, Bujnovszky P et al (1996) Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science 274:1371-1374
7. Tulinius H, Egilsson V, Olafsdottir GH, Sigvaldason H (1992) Risk of prostate, ovarian, and endometrial cancer among relatives of women with breast cancer. BMJ 305:855-857
8. Langston AA, Stanford JL, Wicklund KG, Thompson JD, Blazej RG, Ostrander EA (1996) Germ-line BRCA1 mutations in selected men with prostate cancer. Am J Hum Genet 58:881-885
9. Tonin P, Ghadirian P, Phelan C, Lenoir GM, Lynch HT, Letendre F, Belanger D, Mont M, Narod SA (1995) A large multisite cancer family is linked to BRCA2. J Med Genet 32:982-984
10. Gudmundsson J, Johannesdottir G, Arason A, Bergthorsson JT, Ingvarsson S, Egilsson V, Barkardottir RB (1996) Frequent occurrence of BRCA2 linkage in Icelandic breast cancer families and segregation of a common BRCA2 haplotype. Am J Hum Genet 58:749-756
11. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G et al (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789-792
12. Tavtigian SV, Simard J, Rommens J, Couch F, Shattuck-Eidens D, Neuhausen S, Merajver S, Thorlacius S, Offit K, Stoppa-Lyonnet D et al (1996) The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet 12:333-337
13. Thorlacius S, Olafsdottir G, Tryggvadottir L, Neuhausen S, Jonasson JG, Tavtigian SV, Tulinius H, Ögmundsdottir HM, Eyfjord JE (1996) A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat Genet 13:117-119
14. British Association of Urological Surgeons TNM Subcommittee (1995) The TNM classification of prostate cancer: a discussion of the 1992 classification. Br J Urol 76:279-285
15. Wright DK, Manos MM (1990) Sample preparation from paraffinembedded tissues. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ (eds) PCR protocols - a guide to methods and applications. Academic, San Diego, pp 153-158
16. Gretarsdottir S, Tryggvadottir L, Jonasson JG, Sigurdsson H, Olafsdottir K, Agnarsson BA, Ögmundsdottir H, Eyfjörd JE (1996) TP53 mutation analyses on breast carcinomas; a study of paraffin embedded archival material. Br J Cancer 74:555-561
17. Hakulinen T, Tenkanen E (1987) Regression analysis of relative survival rates. J R Stat Soc series C App Stat 36:309-317